GM16480
LCL from B-Lymphocyte
Description:
RETT SYNDROME; RTT
METHYL-CPG-BINDING PROTEIN 2; MECP2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases GeT-RM Samples |
Class |
Disorders of the Nervous System |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
MECP2 |
Chromosomal Location |
Xq28 |
Allelic Variant 1 |
300005.0016; RETT SYNDROME |
Identified Mutation |
ARG306CYS; In 2 unrelated patients with Rett syndrome (312750), Bourdon et al. [Hum. Genet. 108: 43-50 (2001)] found a 916C-T transition in exon 3 of the MECP2 gene resulting in an arg306-to-cys (R306C) amino acid change. |
Remarks |
Clinically affected; onset at 18 months of age; diagnosed at age 3; EEG showed minor abnormalities; breath holding, swallowing difficulties; growth retardation; limited purposeful hand use; muscle rigidity; some repetitive hand motions; speaks using single words; some circulation problems; occasional tremors; no scoliosis; seizures; small feet; teeth grinding; donor subject has a 916C-T (916C>T) transition in exon 3 of the MECP2 gene resulting in an arg306-to-cys [ARG306CYS (R306C)] amino acid change. |
Kalman LV, Tarleton JC, Percy AK, Aradhya S, Bale S, Barker SD, Bayrak-Toydemir P, Bridges C, Buller-Burckle AM, Das S, Iyer RK, Vo TD, Zvereff VV, Toji LH., Development of a Genomic DNA Reference Material Panel for Rett Syndrome (MECP2-Related Disorders) Genetic Testing. J Mol Diagn.16 (2):273-9 2014 |
PubMed ID: 24508304 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|